Publications by authors named "Kango Nohara"
Background: The choice of an optimal sclerosant for pleurodesis for malignant pleural effusion remains controversial. This retrospective clinical study compared the efficacy and safety of two sclerosants; talc slurry (talc-s) and OK-432.
Methods: We compared the characteristics, 30/90-day success rates, and adverse events in patients with lung adenocarcinoma who underwent pleurodesis by using either OK-432 or talc-s.
A 69-year-old man visited a clinic for left leg weakness. With suspicions of lung cancer and a metastatic brain tumor, he was referred to our hospital and was diagnosed with large cell neuroendocrine carcinoma, cT1bN0M1b (BRA), stage IV. After stereotactic radiosurgery for his brain metastasis, he was treated with chemotherapy containing cisplatin and irinotecan.
View Article and Find Full Text PDFArticle Synopsis
- A clinical stability evaluation for community-acquired pneumonia (CAP) is important, but more research is needed on the time to clinical stability (TCS).
- Among 144 hospitalized patients with pneumococcal pneumonia, the median TCS was 2 days, which was linked to longer hospital stays and worse clinical outcomes.
- Predictors for TCS include the absence of severe pneumonia indicators, and a predictive score can help identify patients at risk for prolonged TCS, with potential implications for improving treatment strategies.